C4orf17
geneOn this page
Also known as DKFZP434G072
Summary
C4orf17 (chromosome 4 open reading frame 17, HGNC:25274) is a protein-coding gene on chromosome 4q23, encoding Uncharacterized protein C4orf17 (Q53FE4).
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 6 total — 1 pathogenic
- MANE Select transcript:
NM_032149
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25274 |
| Approved symbol | C4orf17 |
| Name | chromosome 4 open reading frame 17 |
| Location | 4q23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434G072 |
| Ensembl gene | ENSG00000138813 |
| Ensembl biotype | protein_coding |
| Entrez | 84103 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000326581, ENST00000477187, ENST00000503257, ENST00000514652
RefSeq mRNA: 1 — MANE Select: NM_032149
NM_032149
CCDS: CCDS3649
Canonical transcript exons
ENST00000326581 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000969990 | 99529815 | 99529958 |
| ENSE00001906628 | 99511021 | 99511272 |
| ENSE00001947844 | 99541910 | 99542303 |
| ENSE00002020086 | 99512989 | 99513208 |
| ENSE00003468737 | 99522500 | 99522709 |
| ENSE00003522143 | 99539163 | 99539370 |
| ENSE00003576518 | 99537669 | 99537750 |
| ENSE00003612044 | 99524521 | 99524585 |
| ENSE00003680408 | 99540412 | 99540455 |
Expression profiles
Bgee: expression breadth broad, 28 present calls, max score 94.52.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0534 / max 41.9509, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 49006 | 0.0393 | 3 |
| 49007 | 0.0070 | 3 |
| 49008 | 0.0070 | 3 |
Top tissues by expression
188 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 94.52 | silver quality |
| kidney epithelium | UBERON:0004819 | 92.55 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 88.54 | gold quality |
| buccal mucosa cell | CL:0002336 | 88.36 | gold quality |
| sperm | CL:0000019 | 87.77 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 83.45 | gold quality |
| superficial temporal artery | UBERON:0001614 | 82.93 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.60 | gold quality |
| left testis | UBERON:0004533 | 80.33 | gold quality |
| right testis | UBERON:0004534 | 79.79 | gold quality |
| vastus lateralis | UBERON:0001379 | 79.22 | gold quality |
| testis | UBERON:0000473 | 78.83 | gold quality |
| quadriceps femoris | UBERON:0001377 | 78.53 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 78.26 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 76.26 | gold quality |
| lower lobe of lung | UBERON:0008949 | 75.96 | silver quality |
| upper arm skin | UBERON:0004263 | 75.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 73.86 | gold quality |
| biceps brachii | UBERON:0001507 | 73.13 | gold quality |
| adult organism | UBERON:0007023 | 72.77 | gold quality |
| deltoid | UBERON:0001476 | 71.42 | gold quality |
| vena cava | UBERON:0004087 | 71.01 | gold quality |
| body of tongue | UBERON:0011876 | 70.49 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 70.07 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 69.82 | gold quality |
| tongue | UBERON:0001723 | 69.66 | gold quality |
| cerebellar vermis | UBERON:0004720 | 69.30 | gold quality |
| saphenous vein | UBERON:0007318 | 69.22 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 69.20 | gold quality |
| superior surface of tongue | UBERON:0007371 | 68.90 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.91 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting C4orf17, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-8061 | 99.63 | 69.44 | 1411 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-3171 | 99.49 | 69.06 | 776 |
| HSA-MIR-145-3P | 99.33 | 67.66 | 764 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-6074 | 98.89 | 69.64 | 2187 |
| HSA-MIR-455-5P | 98.74 | 67.31 | 795 |
| HSA-MIR-3928-5P | 98.50 | 67.48 | 980 |
| HSA-MIR-6806-3P | 98.50 | 67.31 | 980 |
| HSA-MIR-376A-5P | 97.70 | 65.61 | 863 |
| HSA-MIR-1227-3P | 97.36 | 66.94 | 834 |
| HSA-MIR-500B-3P | 96.49 | 65.40 | 1087 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 4930579F01Rik | ENSMUSG00000012042 |
| rattus_norvegicus | C2h4orf17 | ENSRNOG00000024623 |
Protein
Protein identifiers
Uncharacterized protein C4orf17 — Q53FE4 (reviewed: Q53FE4)
All UniProt accessions (2): D6RHU4, Q53FE4
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q53FE4-1 | 1 | yes |
| Q53FE4-2 | 2 |
RefSeq proteins (1): NP_115525* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037394 | TBATA-like | Family |
Pfam: PF15256
UniProt features (13 total): region of interest 3, sequence variant 3, compositionally biased region 3, splice variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q53FE4-F1 | 56.75 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
TTTGTAG_MIR520D, MODULE_95, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, MODULE_163, FOXN3_TARGET_GENES, NME2_TARGET_GENES, MIR579_3P, MIR664B_3P, MIR664A_3P, MIR7154_5P, MIR6806_3P, MIR3928_5P, MIR1227_3P, GSE13306_RA_VS_UNTREATED_TCONV_DN, GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
144 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C4orf17 | LKAAEAR1 | Q8TD35 | 670 |
| C4orf17 | ZNF512 | Q96ME7 | 578 |
| C4orf17 | ARRDC5 | A6NEK1 | 507 |
| C4orf17 | NT5C1B | Q96P26 | 433 |
| C4orf17 | DNAJC17 | Q9NVM6 | 418 |
| C4orf17 | DIPK1C | Q0P6D2 | 397 |
| C4orf17 | TDRD12 | Q587J7 | 391 |
| C4orf17 | TBCK | Q8TEA7 | 380 |
| C4orf17 | LRMDA | Q9H2I8 | 371 |
| C4orf17 | ZNF536 | O15090 | 359 |
| C4orf17 | TREML4 | Q6UXN2 | 348 |
| C4orf17 | ADH1C | P00326 | 330 |
| C4orf17 | ADH7 | P40394 | 328 |
| C4orf17 | GAGE4 | P0DSO3 | 327 |
| C4orf17 | PGAP1 | Q75T13 | 324 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NCK2 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C4orf17 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LONRF1 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C4orf17 | ABI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C4orf17 | HOMER3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C4orf17 | CCN2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CRK | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SUV39H1 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.370 |
| C4orf17 | KDM1A | psi-mi:“MI:0915”(physical association) | 0.370 |
| C4orf17 | PRMT1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NCK2 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GRN | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF417 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LONRF1 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ABI2 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C4orf17 | HOMER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HOMER3 | C4orf17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C4orf17 | CHD3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C4orf17 | COPS6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C4orf17 | SH3GL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C4orf17 | TUBA4A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): C4orf17 (Two-hybrid), TUBA4A (Two-hybrid), C4orf17 (Two-hybrid), C4orf17 (Two-hybrid), C4orf17 (Two-hybrid), CHD3 (Two-hybrid), COPS6 (Two-hybrid), SH3GL3 (Two-hybrid), C4orf17 (Two-hybrid), LONRF1 (Two-hybrid), ZNF417 (Two-hybrid), CTGF (Affinity Capture-MS), SRRM1 (Cross-Linking-MS (XL-MS)), KDM1A (Two-hybrid), PRMT1 (Two-hybrid)
ESM2 similar proteins: A0JNF3, A4L9P8, A5WUN7, A6H5Y1, D4AEC2, E9PV87, E9Q309, H6D7E6, O54931, P28290, Q08AD1, Q09JY9, Q1G7G9, Q2KHM9, Q2MJV9, Q2T9X8, Q3KQW7, Q3MHH7, Q49A88, Q4KLH6, Q4KM62, Q53FE4, Q5PQL8, Q5RBY6, Q5RKG1, Q5VT06, Q66H16, Q66H35, Q6A000, Q6DF94, Q6NSV7, Q6ZQ06, Q7ZX27, Q80VP2, Q8BQ48, Q8C804, Q8K2J4, Q8N0Z3, Q8NA03, Q8R2H7
Diamond homologs: Q4R616, Q53FE4, Q7TSD4, Q32KL8, Q96M53
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2427353 | NC_000004.11:g.(?100239320)(100528137_?)del | Pathogenic |
SpliceAI
1214 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:99522681:TGCCA:T | donor_gain | 1.0000 |
| 4:99522715:T:G | donor_gain | 1.0000 |
| 4:99524519:A:AG | acceptor_gain | 1.0000 |
| 4:99524520:G:GG | acceptor_gain | 1.0000 |
| 4:99540404:T:A | acceptor_gain | 1.0000 |
| 4:99540455:GGT:G | donor_gain | 1.0000 |
| 4:99541908:A:AG | acceptor_gain | 1.0000 |
| 4:99541909:G:GG | acceptor_gain | 1.0000 |
| 4:99511105:G:GT | donor_gain | 0.9900 |
| 4:99522483:A:AG | acceptor_gain | 0.9900 |
| 4:99522490:A:AG | acceptor_gain | 0.9900 |
| 4:99522496:CTAG:C | acceptor_loss | 0.9900 |
| 4:99522497:TAGG:T | acceptor_loss | 0.9900 |
| 4:99522498:A:AG | acceptor_gain | 0.9900 |
| 4:99522499:G:A | acceptor_loss | 0.9900 |
| 4:99522499:G:GG | acceptor_gain | 0.9900 |
| 4:99522499:GGCTT:G | acceptor_gain | 0.9900 |
| 4:99522707:CTGGT:C | donor_loss | 0.9900 |
| 4:99522710:G:C | donor_loss | 0.9900 |
| 4:99522711:T:A | donor_loss | 0.9900 |
| 4:99524515:TTTCA:T | acceptor_loss | 0.9900 |
| 4:99524516:TTCA:T | acceptor_loss | 0.9900 |
| 4:99524518:CA:C | acceptor_loss | 0.9900 |
| 4:99524519:A:AT | acceptor_loss | 0.9900 |
| 4:99524520:GA:G | acceptor_gain | 0.9900 |
| 4:99524584:AGGT:A | donor_loss | 0.9900 |
| 4:99524585:GGTA:G | donor_loss | 0.9900 |
| 4:99524586:G:GA | donor_loss | 0.9900 |
| 4:99524587:T:A | donor_loss | 0.9900 |
| 4:99529959:G:GG | donor_gain | 0.9900 |
AlphaMissense
2348 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:99537726:T:A | W202R | 0.996 |
| 4:99537726:T:C | W202R | 0.996 |
| 4:99513208:G:C | G43R | 0.992 |
| 4:99537730:T:C | L203P | 0.991 |
| 4:99522520:T:C | C50R | 0.990 |
| 4:99537728:G:C | W202C | 0.990 |
| 4:99537728:G:T | W202C | 0.990 |
| 4:99522522:T:G | C50W | 0.988 |
| 4:99513199:C:G | H40D | 0.987 |
| 4:99537705:T:C | S195P | 0.986 |
| 4:99537727:G:C | W202S | 0.986 |
| 4:99537682:T:C | L187P | 0.985 |
| 4:99537694:T:C | L191S | 0.985 |
| 4:99513171:G:C | R30S | 0.984 |
| 4:99513171:G:T | R30S | 0.984 |
| 4:99539175:T:A | V214D | 0.984 |
| 4:99513194:T:A | V38D | 0.983 |
| 4:99522503:T:C | L44S | 0.983 |
| 4:99513170:G:T | R30M | 0.982 |
| 4:99537738:G:C | A206P | 0.982 |
| 4:99539167:A:C | K211N | 0.982 |
| 4:99539167:A:T | K211N | 0.982 |
| 4:99513201:C:A | H40Q | 0.981 |
| 4:99513201:C:G | H40Q | 0.981 |
| 4:99522520:T:A | C50S | 0.981 |
| 4:99522521:G:A | C50Y | 0.981 |
| 4:99522521:G:C | C50S | 0.981 |
| 4:99537673:T:C | L184P | 0.981 |
| 4:99537739:C:A | A206E | 0.980 |
| 4:99513170:G:C | R30T | 0.979 |
dbSNP variants (sampled 300 via entrez): RS10000018 (4:99537291 A>G), RS1000064080 (4:99525759 T>C), RS1000079019 (4:99519715 G>A), RS1000102870 (4:99516605 G>C), RS1000157121 (4:99535156 G>A), RS1000318707 (4:99528630 G>A), RS1000387175 (4:99528368 C>A,T), RS1000441915 (4:99535366 G>C), RS1000568404 (4:99521307 A>C), RS10005769 (4:99521683 C>T), RS1000673832 (4:99542520 C>A), RS1000709578 (4:99515187 A>C), RS1000777732 (4:99513566 A>G), RS10007975 (4:99527667 C>T), RS1000871894 (4:99523976 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001822_7 | Metabolite levels (MHPG) | 8.000000e-06 |
| GCST001960_8 | Eating disorders | 8.000000e-06 |
| GCST002112_3 | Celiac disease | 5.000000e-06 |
| GCST005356_2 | Severe malaria | 4.000000e-07 |
| GCST005357_12 | Severe malaria (adjusted for sickle cell variant rs334) | 9.000000e-07 |
| GCST006921_3 | Regular attendance at a pub or social club | 4.000000e-25 |
| GCST007328_36 | Alcohol consumption (drinks per week) | 3.000000e-10 |
| GCST008758_23 | Pre-treatment viral load in HIV-1 infection | 2.000000e-16 |
| GCST90011898_160 | Alanine aminotransferase levels | 2.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005133 | MHPG measurement |
| EFO:0009592 | social interaction measurement |
| EFO:0010125 | viral load |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Rotenone | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): eating disorder